{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:25:01Z","timestamp":1761236701815},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2000,5,1]],"date-time":"2000-05-01T00:00:00Z","timestamp":957139200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2000,5]]},"DOI":"10.1006\/clim.2000.4854","type":"journal-article","created":{"date-parts":[[2002,9,16]],"date-time":"2002-09-16T15:45:11Z","timestamp":1032191111000},"page":"145-155","source":"Crossref","is-referenced-by-count":22,"title":["Glycyrrhizin Improves the Resistance of MAIDS Mice to Opportunistic Infection of Candida albicans through the Modulation of MAIDS-Associated Type 2 T Cell Responses"],"prefix":"10.1006","volume":"95","author":[{"given":"Tokuichiro","family":"Utsunomiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makiko","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B","family":"Pollard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fujio","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/clim.2000.4854_RF1","first-page":"627","article-title":"Wound infection following trauma and burn injuries","volume":"7","author":"Klein","year":"1995","journal-title":"Infect. Control Crit. Care"},{"key":"10.1006\/clim.2000.4854_RF2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s002770050306","article-title":"Management of infections during intensive treatment of hematologic malignancies","volume":"75","author":"Maschmeyer","year":"1997","journal-title":"Ann. Hematol."},{"key":"10.1006\/clim.2000.4854_RF3","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/sj.bmt.1700686","article-title":"Mycobacterial infections following bone marrow transplantation: A 20 year retrospective review","volume":"19","author":"Roy","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"10.1006\/clim.2000.4854_RF4","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00002030-199801000-00004","article-title":"Impact of opportunistic disease on survival in patients with HIV infection","volume":"12","author":"Chaisson","year":"1998","journal-title":"AIDS"},{"key":"10.1006\/clim.2000.4854_RF5","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1111\/j.1601-0825.1997.tb00383.x","article-title":"Selection and pathogenicity of Candida albicans in HIV infection","volume":"3","author":"Sweet","year":"1997","journal-title":"Oral Dis."},{"key":"10.1006\/clim.2000.4854_RF6","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1097\/00002030-199207000-00001","article-title":"Retrovirus-induced immunodeficiency in the mouse: MAIDS as a model for AIDS","volume":"6","author":"Morse","year":"1992","journal-title":"AIDS"},{"key":"10.1006\/clim.2000.4854_RF7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.4049\/jimmunol.148.1.182","article-title":"CD4+ subset regulation in viral infection: Preferential activation of Th2 cells during progression retrovirus-induced immunodeficiency in mice","volume":"148","author":"Gazzinelli","year":"1992","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2000.4854_RF8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1159\/000058688","article-title":"Initiation of T-helper cell immunity to Candida albicans by IL-12: The role of neutrophils","volume":"68","author":"Romani","year":"1997","journal-title":"Chem. Immunol."},{"key":"10.1006\/clim.2000.4854_RF9","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0165-2478(94)00183-R","article-title":"Glycyrrhizin (20\u03b2-carboxy-11-oxo-30-norolean-12-en-3\u03b2-yl-2-O-\u03b2-d-glucopyranuronosyl-\u03b1-d-glucopyranosiduronic acid) improves the resistance of thermally injured mice to opportunistic infection of herpes simplex virus type 1","volume":"44","author":"Utsunomiya","year":"1995","journal-title":"Immunol. Lett."},{"key":"10.1006\/clim.2000.4854_RF10","first-page":"A271","article-title":"Recovery of impaired IL-12 production in thermally injured mice treated with glycyrrhizin (GR), an active component of licorice roots","volume":"12","author":"Utsunomiya","year":"1998","journal-title":"FASEB J."},{"key":"10.1006\/clim.2000.4854_RF11","doi-asserted-by":"crossref","unstructured":"Nakajima, N., Utsunomiya, T., Kobayashi, M., Herndon, D. N., Pollard, R. B., and Suzuki, F., In vitro induction of anti-type 2 T cells by glycyrrhizin. Burns22, 612\u2013617, 1996.","DOI":"10.1016\/S0305-4179(96)00053-8"},{"key":"10.1006\/clim.2000.4854_RF12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/icb.1993.20","article-title":"Inhibition of burn-associated suppressor cell generation by glycyrrhizin through the induction of contrasuppressor T cells","volume":"71","author":"Kobayashi","year":"1993","journal-title":"Immunol. Cell Biol."},{"key":"10.1006\/clim.2000.4854_RF13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1002\/jlb.58.2.159","article-title":"CD4+ contrasuppressor T cells improve the resistance of thermally injured mice infected with HSV","volume":"58","author":"Kobayashi","year":"1995","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clim.2000.4854_RF14","first-page":"423","article-title":"Effects of glycyrrhizin on biomedical tests in patients with chronic hepatitis-double blind trial","volume":"26","author":"Suzuki","year":"1983","journal-title":"Asian Med. J."},{"key":"10.1006\/clim.2000.4854_RF15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1046\/j.1365-2036.1998.00309.x","article-title":"Review article: Glycyrrhizin as a potential treatment for chronic hepatitis C","volume":"12","author":"Van Rossum","year":"1998","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1006\/clim.2000.4854_RF16","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/(SICI)1097-0142(19970415)79:8<1494::AID-CNCR8>3.0.CO;2-B","article-title":"The long term efficacy of glycyrrhizin in chronic hepatitis C patients","volume":"79","author":"Arase","year":"1997","journal-title":"Cancer"},{"key":"10.1006\/clim.2000.4854_RF17","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/jlb.55.1.24","article-title":"Effect of glycyrrhizin, cyclosporin A, and tumor necrosis factor \u03b1 on infection of U-937 and MRC-5 cells by human cytomegalovirus","volume":"55","author":"Numazaki","year":"1994","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clim.2000.4854_RF18","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1038\/281689a0","article-title":"Glycyrrhizic acid inhibits virus growth and inactivates virus particles","volume":"281","author":"Pompei","year":"1979","journal-title":"Nature"},{"key":"10.1006\/clim.2000.4854_RF19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1128\/AAC.41.3.551","article-title":"Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus","volume":"41","author":"Utsunomiya","year":"1997","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1006\/clim.2000.4854_RF20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0166-3542(88)90047-2","article-title":"Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV)","volume":"10","author":"Ito","year":"1988","journal-title":"Antiviral Res."},{"key":"10.1006\/clim.2000.4854_RF21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1620\/tjem.158.25","article-title":"Effect of glycyrrhizin (SNMC: Stronger Neo-Minophagen C) in hemophilia patients with HIV infection","volume":"158","author":"Mori","year":"1989","journal-title":"Tohoku J. Exp. Med."},{"key":"10.1006\/clim.2000.4854_RF22","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1046\/j.1440-1711.1998.00735.x","article-title":"The regulation of burn-associated infection with herpes simplex virus type 1 or Candida albicans by a non-toxic aconitine-hydrolysate, benzoylmesaconine","volume":"76","author":"Kobayashi","year":"1998","journal-title":"Immunol. Cell Biol."},{"key":"10.1006\/clim.2000.4854_RF23","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1073\/pnas.86.10.3862","article-title":"A defective virus is associated with induction of murine retrovirus-induced immunodeficiency syndrome, MAIDS","volume":"86","author":"Chattopadhyay","year":"1989","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/clim.2000.4854_RF24","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/0042-6822(70)90362-4","article-title":"Plaque assay techniques for murine leukemia viruses","volume":"42","author":"Rowe","year":"1971","journal-title":"Virology"},{"key":"10.1006\/clim.2000.4854_RF25","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1128\/AAC.39.10.2197","article-title":"Fluconazole treatment of Candida albicans infection in mice: Does in vitro susceptibility predict in vivo response?","volume":"39","author":"Graybill","year":"1995","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1006\/clim.2000.4854_RF26","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/jlb.63.6.723","article-title":"Burn-associated Candida albicans infection caused by CD30+ type 2 T cells","volume":"63","author":"Kobayashi","year":"1998","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clim.2000.4854_RF27","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/jlb.44.3.166","article-title":"Role of activated macrophages in resistance to systemic candidosis","volume":"44","author":"Baghian","year":"1988","journal-title":"J. Leukocyte Biol."},{"key":"10.1006\/clim.2000.4854_RF28","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/cimm.1996.1074","article-title":"Differential effects of granulocyte\/macrophage colony-stimulating factor (GM-CSF) in enhancing macrophage resistance to Legionella pneumophila vs Candida albicans","volume":"176","author":"Yamamoto","year":"1997","journal-title":"Cell. Immunol."},{"key":"10.1006\/clim.2000.4854_RF29","doi-asserted-by":"crossref","first-page":"284","DOI":"10.4049\/jimmunol.160.1.284","article-title":"The role of recombinant murine IL-12 and IFN-\u03b3 in the pathogenesis of murine systemic Candida albicans infection","volume":"160","author":"Lavigne","year":"1998","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2000.4854_RF30","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1086\/514027","article-title":"Induction of protective Th1 responses to Candida albicans by antifungal therapy alone or in combination with an interleukin-4 antagonist","volume":"176","author":"Cenci","year":"1997","journal-title":"J. Infect. Dis."},{"key":"10.1006\/clim.2000.4854_RF31","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1128\/IAI.59.12.4647-4654.1991","article-title":"Th1 and Th2 cytokine secretion patterns in murine candidiasis: Association of Th1 responses with acquired resistance","volume":"59","author":"Romani","year":"1991","journal-title":"Infect. Immun."},{"key":"10.1006\/clim.2000.4854_RF32","doi-asserted-by":"crossref","first-page":"925","DOI":"10.4049\/jimmunol.150.3.925","article-title":"CD4+ subset expression in murine candidiasis: Th responses correlate directly with genetically determined susceptibility or vaccine-induced resistance","volume":"150","author":"Romani","year":"1993","journal-title":"J. Immunol."},{"key":"10.1006\/clim.2000.4854_RF33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"Mosmann","year":"1989","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/clim.2000.4854_RF34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1600-065X.1992.tb01414.x","article-title":"Role of T-cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection","volume":"127","author":"Sher","year":"1992","journal-title":"Immunol. Rev."},{"key":"10.1006\/clim.2000.4854_RF35","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1146\/annurev.iy.11.040193.000333","article-title":"Differential regulation of murine lymphocyte subsets","volume":"11","author":"Fitch","year":"1993","journal-title":"Annu. Rev. Immunol."},{"key":"10.1006\/clim.2000.4854_RF36","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0167-5699(96)80606-2","article-title":"The expanding universe of T-cell subsets: Th1, Th2 and more","volume":"17","author":"Mosmann","year":"1996","journal-title":"Immunol. Today"},{"key":"10.1006\/clim.2000.4854_RF37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1084\/jem.176.1.19","article-title":"Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis","volume":"176","author":"Romani","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1006\/clim.2000.4854_RF38","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/infdis\/169.6.1325","article-title":"Cure of murine candidiasis by recombinant soluble interleukin-4 receptor","volume":"169","author":"Puccetti","year":"1994","journal-title":"J. Infect. Dis."},{"key":"10.1006\/clim.2000.4854_RF39","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.8023143","article-title":"Lack of evidence for the dichotomy of TH1 and TH2 predominance in HIV-infected individuals","volume":"265","author":"Graziosi","year":"1994","journal-title":"Science"},{"key":"10.1006\/clim.2000.4854_RF40","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-065X.1994.tb00865.x","article-title":"Role of TH1\/TH2 cytokines in HIV infection","volume":"140","author":"Romagnani","year":"1994","journal-title":"Immunol. Rev."},{"key":"10.1006\/clim.2000.4854_RF41","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0167-5699(94)90220-8","article-title":"The Th1\u2013Th2 hypothesis of HIV infection: New insights","volume":"15","author":"Clerici","year":"1994","journal-title":"Immunol. Today"},{"key":"10.1006\/clim.2000.4854_RF42","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00002030-199406000-00006","article-title":"TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV-infected patients","volume":"8","author":"Barcellini","year":"1994","journal-title":"AIDS"},{"key":"10.1006\/clim.2000.4854_RF43","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/clim.2000.4854_RF44","series-title":"AIDS Clinical Review","first-page":"145","article-title":"HIV-1 protease inhibitors","author":"Deeks","year":"1998"},{"key":"10.1006\/clim.2000.4854_RF45","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S0167-5699(98)01353-X","article-title":"HIV infection: How effective is drug combination treatment?","volume":"19","author":"Grossman","year":"1998","journal-title":"Immunol. Today"},{"key":"10.1006\/clim.2000.4854_RF46","first-page":"S295","article-title":"Immunologic therapy for HIV-infected individuals, 1993\u20131994","volume":"8","author":"Pollard","year":"1994","journal-title":"AIDS"},{"key":"10.1006\/clim.2000.4854_RF47","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/8394","article-title":"Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy","volume":"5","author":"Finzi","year":"1999","journal-title":"Nature Med."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166160094854X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166160094854X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,4,3]],"date-time":"2023-04-03T18:52:23Z","timestamp":1680547943000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166160094854X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,5]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2000,5]]}},"alternative-id":["S152166160094854X"],"URL":"https:\/\/doi.org\/10.1006\/clim.2000.4854","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2000,5]]}}}